In the recent past, our client - one of TOP 10 GLOBAL Biotechnology companies, with the geographical footprint in 68 countries.
Study Design: Phase II, Randomized, Double blind, Placebo controlled study to evaluate the Safety and efficacy of study drug in Ovarian Cancer patients.
Pediatric Type I diabetes mellitus
Issue: PACE was approached by the sponsor as a part of rescue arrangement to get patient recruitment on track for this phase IIb, Type I pediatric diabetes study. The time when the study was awarded to PACE, it recruited 40% of patients by then (in 16 months).
Pediatric Type II Diabetes
Study Design: Phase III, Randomized, Double blind, Placebo controlled study to evaluate the Safety and efficacy of study drug in Pediatric Type 2 Diabetes patients.
Indication: Meningococcal Vaccines study for pediatric population